Clenbuterol, tablets 20 mcg 50 pcs

Bronchitis, Learning Disabilities, Bronchial AsthmaBronchial asthma, chronic obstructive pulmonary disease.

Indications

Bronchial asthma, chronic obstructive pulmonary diseases.

Pharmacological effect

Clenbuterol is a selective β2-adrenergic agonist.

Active ingredient

Clenbuterol

Composition

Active substance:

Clenbuterol hydrochloride – 5 mcg.

Excipients:

lactose monohydrate – 70 mg;

wheat starch – 31.48 mg;

MCC – 48.5 mg;

colloidal silicon dioxide – 2 mg;

magnesium stearate – 2 mg;

povidone (povidone K25) – 6 mg

Contraindications

Contraindicated during pregnancy and breastfeeding.

Side Effects

From the cardiovascular system: tachycardia, extrasystole, arterial hypo- or (more often) hypertension, cardialgia, facial hyperemia.

From the central nervous system and peripheral nervous system: tremor of the fingers, anxiety, headache, dizziness, general weakness, insomnia, paresthesia.

From the digestive system: dry mouth, nausea, vomiting, gastralgia.

Allergic reactions: skin rash, urticaria, bronchospasm, angioedema.

Other: increased sweating, hypokalemia, muscle cramps. If the drug is abruptly discontinued, resistance and rebound syndrome may develop. When used in large doses, it causes tremor of the fingers.

Overdose

Symptoms: arrhythmia, tachycardia, arterial hypertension, cardialgia, tremor of the limbs, possible development of hypokalemia.

Treatment: gastric lavage, administration of activated carbon, use of water-salt solutions, monitoring the level of potassium in the blood serum, symptomatic therapy.

Storage conditions

List B.

Shelf life

3 years.

Do not use after the expiration date stated on the package.

Manufacturer

Sopharma JSC, Bulgaria